Dynorphins
Brand name:- not available.
Dynorphin is under investigation in clinical trial NCT00000244 (Effects of Dynorphin 1-13 on Heroin Addiction - 1). Dynorphins A and B ( DYN- A , DYN-B ) are 8-17 amino acid peptides derived from prodynorphin which contains 3 leu- ENK residues also. DYNs are more potent on k receptors, but also activate ú and § receptors.
Pharmacodynamic:-
Not available 🚫
Mechanism of action:-
Dynorphin, an endogenous opiate, when released at the level of the spinal cord is thought to increase the release of excitatory neurotransmitters from the primary afferents thereby causing amplification of the afferent sensory signal. Evidence for this pro-nociceptive role comes from observations that dynorphin is increased in chronic pain states and that pain behaviours in animals are attenuated following the administration of dynorphin antagonists . Chronic opiate use leads to up-regulation of dynorphin production at the spinal dorsal horn, which induces further hyperalgesia. By blocking this effect hyperalgesia is reduced, analgesia is restored and opiate tolerance is prevented.
Used:-
Based on the localization of the κ-opioid receptor, dynorphins are involved in learning and memory, emotional control, and stress response, in addition to analgesic effects.
Side effects:-
Common side effects.
Comments
Post a Comment